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 Introduction 
 Over 25 years ago, the human immunodeficiency vi-
rus, HIV-1, was discovered. Up till now, no protective 
vaccine has been developed. Particularly in sub-Saharan 
Africa, HIV/AIDS is one of the leading causes of death 
among young adults. Prevalence data are vital for track-
ing the progress of the HIV epidemic. In most countries 
in sub-Saharan Africa, this is monitored by sentinel sur-
veillance among pregnant women attending an antenatal 
clinic (ANC). Because heterosexual intercourse is the 
main mode of HIV transmission in these countries, the 
prevalence of infection among attendees of ANCs is usu-
ally assumed to be representative of the general popula-
tion (males and females of reproductive age  [1, 2] ). A 
trend in HIV-1 prevalence in a particular region cannot 
be determined by an anonymous sentinel surveillance 
among pregnant women attending an ANC at one time. 
Therefore, longitudinal surveillance needs to be per-
formed over several years. The present national HIV-1 
sentinel surveillance system currently involves 19 ANCs 
located in 18 of the country’s 56 districts. Furthermore, 
the national PMTCT (Prevention of Mother-To-Child 
Transmission) program, which was created by the Ugan-
dan Ministry of Health in 2000, currently involves health 
facilities in 35 districts.
 This longitudinal epidemiological study was conduct-
ed to examine the prevalence of HIV-1 infection in cor-
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 Abstract 
 Introduction: In order to determine the development of the 
prevalence of HIV infection in rural Western Uganda, data of 
epidemiological studies conducted in 2001 and 2007 were 
compared to study data from 1993.  Methods: In 2001 (n = 
466) and in 2007 (n = 486), one group each of clinically 
healthy pregnant women of a local prenatal care depart-
ment were enrolled in the study and anonymously screened 
for HIV-1. For both groups, informed consent was obtained 
prior to enrolment. Testing for HIV was done by enzyme-
linked immunosorbent assay (ELISA) and confirmed by West-
ern blot. In addition, age and antibodies against syphilis 
were determined as risk factors of HIV infection.  Results: The 
seroprevalence of HIV-1 infection did not decrease signifi-
cantly over this time period, dropping from 28.3 to 25.1% 
between 2001 and 2007, but the prevalence of syphilis anti-
bodies decreased from 27.9 to 11.1%. The data of 2001 and 
2007 were compared to a third cohort from 1993, in which 
21.5% of pregnant women were HIV-1-positive and 31.1% 
were Treponema pallidum hemagglutination assay (TPHA)-
positive.  Conclusion: The current prevalence of HIV-1 infec-
tion in Uganda is still high and there is a need for further 
promotion of HIV prevention and control services. 
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relation to other sexually transmitted diseases (STDs) 
and age ranges in rural Uganda over a period of almost 
15 years.
 Material and Methods 
 Integrated Population and Sample Collection 
 At three time points, each about 6–8 years apart, pregnant 
women attending a dispensary in South Western Uganda were 
examined for HIV antibodies: there were 409 in 1993, 466 in 2001 
and 486 in 2007. Our data were assessed as an ‘Anonymous and 
Unlinked Sentinel Sero-Surveillance Study’ in a small unlisted 
ANC unit in Western Uganda, in addition to the 19 mentioned 
ANCs of the country’s national HIV-1 sentinel surveillance sys-
tem. Bujumbura Health Center is provided by the Catholic Church 
and is mainly supported by the Banyatereza Sisters. Located 
south-east of Hoima town, it is frequented by urban as well as ru-
ral patients from different parts of the country district. After hav-
ing given informed consent, female attendees of an antenatal clin-
ic who were up to 38 weeks’ pregnant and comparable with regard 
to their age (11–54 years old) were enrolled in this study as repre-
sentatives of the fertile, sexually active population. Study samples 
were obtained anonymously and consecutively at each visit with-
in a period of 6 months. All the women included came from the 
local district and were ethnically Bunyoro. Study participants 
were also screened for syphilis antibodies in correlation to their 
HIV status. Immediately after data analysis, our results were re-
ported to the Ugandan Ministry of Health as a cooperating part-
ner.
 Serology 
 The sera samples for HIV and syphilis were obtained anony-
mously from pregnant women. First testing for HIV antibodies 
was done by ELISA (New ABBOTT AxSYM HIV Ag/Ab Combo 
Assay, ABBOTT Wiesbaden, Germany). Nonvalid, unclear and 
reactive samples were confirmed by Western blot (INNO-LIA T-
MM HIV I/II Score, Innogenetics, STD Technology for Health 
Care, Hannover, Germany). In 2007, confirming tests (Western 
blot) showed unspecified results in six blood samples (1.2%), 
which would have required a further blood sample. Because our 
‘Anonymous and Unlinked Sentinel Sero-Surveillance Study’ in-
vestigated one ‘status quo’ at one time, these unspecific samples 
were excluded.
 Syphilis serology was done by Treponema pallidum 
hemagglutination assay (TPHA, Mast Diagnostica, ‘Laborato-
riumspräparate GmbH’, Reinfeld, Germany).
 Statistical Analysis 
 Data management and statistical analysis were conducted in 
SPSS version 15.0 (SPSS Inc., Chicago, Ill., USA). Continuous 
variables were summarized by means of the median, the 
interquartile (IQR, 25th–75th percentile), and the minimum to 
maximum range. For categorical data, frequency counts and 
percentages were calculated. Between-group comparisons were 
assessed with the Mann-Whitney-U test for continuous variables 
and the Pearson χ 2 test for categorical variables. All tests were 
done at the 5% two-sided significance level. Odds ratios (OR) and 
corresponding 95% confidence intervals (CI) were calculated and 
considered statistically significant if the CI exceeded 1.0. No 
adjustment for multiple testing was conducted. We calculated 
HIV-1 prevalence and exact binomial CI. The OR obtained by 
running logistical regression models were used to describe 
changes at the two time points regarding the risk of HIV-1 
infection. The χ 2 for linear trend tests was used for univariate 
analysis.
 Results 
 Demographic Data 
 A total of 952 women met the inclusion criteria and 
were available for analysis, 466 (48.9%) in 2001 and 486 
(51.1%) in 2007.
 The median age of the entire study population was 
25  years (range 11–54 years). The women in the 2007 
study group were significantly (p = 0.001) younger 
than the women in the study group of 2001: the median 
age of the study population in 2001 was 26.3 years 
ranging from 11 to 51 years, whereas in 2007 the median 
age was 24.7 years ranging from 14 to 55 years. So, in 
2001, most participants belonged to the age group 25–29 
years and in 2007, the age peak was the period 20–24 
years ( table 1 ).
 Altogether, the population surveys did not differ 
significantly (p = 0.235). No differences could be found 
Table 1.  Age distribution of total number of participating pregnant 
women in 2001 and 2007
Year 2001  2007
n % n %
Total n 466 486
Age, years
≤15 6 1.3 1 0.2
<15–19 89 19.1 103 21.2
<20–24 110 23.6 155 31.9
<25–29 114 24.5 109 22.4
<30–34 68 14.6 57 11.7
<35–39 55 11.8 31 6.4
<40–44 21 4.5 5 1.0
>44 2 0.4 3 0.6
<Unknown 1 0.2 22 4.5
Median, IQR 26 20–31 24 20–28
 Median and IQR were determined. Eight age-ranges were 
defined (<15, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44 and >44 
years old). In 2001, only 1 (0.2%) and in 2007, 22 (4.5%) pregnant 
women were not aware of their age.
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in the type of residence: all 2001 and 2007 participants 
belonged to rural populations.
 With regard to the validity of data on age, 456 (99.8%) 
of the women in 2001 and 464 (95.5%) in 2007 knew 
their age i.e. one patient in 2001 and 22 in 2007, respec-
tively, did mention that they were not aware of their exact 
age ( table 1 ). All other women and/or girls gave their age 
with or without a passport or birth certification.
 Prevalence of HIV among Pregnant Women 
 In 2001, 132 (28.3%) of the 466 pregnant women with-
out symptoms were found HIV-positive by confirmed 
testing (Western blot) and 334 (71.7%) were HIV-nega-
tive.
 In comparison, in 2007, 122 (25.1%) of the 486 part-
icipating pregnant women tested HIV-positive and 358 
(73.7%) were HIV-negative which shows a decrease in 
HIV prevalence of 3.2%, which is not significant (p = 
0.129).
 In 2001, the highest percentage of HIV positivity was 
found among pregnant women in the age group 25–29 
years. In 2007, this was a younger age group of 20–24 
years, i.e. the peak of HIV prevalence in pregnant women 
changed ( table 2 ).
 Seroprevalence of Syphilis Antibody Positivity among 
Pregnant Women 
 In 2001, 130 out of 466 pregnant women tested Trepo-
nema pallidum hemagglutination assay (TPHA)-positive 
(27.9%). In 2007, only 54 (11.1%) out of 488 pregnant 
women were syphilis antibody-positive, i.e. there was a 
significant (p < 0.001) reduction of seropre valence of 
TPHA positivity. In 2001, the highest prevalence of 32.7% 
was found in the age group of 20–24 years. A second peak 
was found in the age group of 40–44 years with 33.3%. In 
2007, TPHA positivity, in correlation to age, peaked 
twice: first among the 35- to 39-year olds with 29.0%, and 
secondly, among the older than 44-year-olds with 66.7%. 
This last value cannot be considered striking because the 
second peak was caused by 2 pregnant women out of only 
3 TPHA-positive patients, i.e. the number of random 
samples was very low ( table 3 ).
 Simultaneous HIV and Syphilis Infection 
 An interesting correlation emerged between simulta-
neous HIV and syphilis infection. In 2001, 45 out of 466 
pregnant women (9.7%) were simultaneously infected 
with HIV-1 and syphilis. Thus, out of 132 pregnant wom-
en who were seroreactive for HIV-1, and out of 130 preg-
nant women who were positive for syphilis antibody in 
2001, 45 women had acquired both infections. In 2007, 
this infection rate decreased to only 3.9%, i.e. 19 out of 
122 HIV-positive women and 54 TPHA-positive women 
were HIV-positive and TPHA/syphilis anti body-positive, 
which represents a considerably significant reduction in 
simultaneous HIV and syphilis infection (OR = 2.63, 95% 
CI 1.51–4.56, p < 0.001) ( table 4 ;  fig. 1 ).
 Discussion 
 The prevalence of HIV-1 infection among women of 
reproductive age was and is increasing worldwide  [3–5] . 
Uganda is a country known to make a difference.
Table 2.  HIV-1 serology status by age group
Year 2001  2007
n % n %
Patients, 
total n
466 486
Age, years
<15 positive 2 33.3 positive 0 0.0
negative 4 66.7 negative 1 100.0
<15–19 positive 24 27.0 positive 19 18.4
negative 65 73.0 negative 83 80.6
invalid 1 1.0
<20–24 positive 27 24.5 positive 41 26.5
negative 83 75.5 negative 111 71.6
invalid 3 1.9
<25–29 positive 42 36.8 positive 28 25.7
negative 72 63.2 negative 81 74.3
<30–34 positive 16 23.5 positive 15 26.3
negative 52 76.5 negative 41 71.9
invalid 1 1.8
<35–39 positive 14 25.5 positive 8 25.8
negative 41 74.5 negative 22 71.0
invalid 1 3.2
<40–44 positive 6 28.6 positive 1 20.0
negative 15 71.4 negative 4 80.0
>44 positive 1 50.0 positive 0 0.0
negative 1 50.0 negative 3 100.0
<Unknown positive 0 0.0 positive 10 45.5
negative 1 100.0 negative 12 54.5
Median: 26, IQR: 20–31 24, IQR: 20–28
Summarized positive 132 28.3 positive 122 25.1
negative 334 71.7 negative 358 73.7
invalid 6 1.2
 Number and age distribution of HIV-1-positive and -HIV-
negative pregnant women in the 2 studies in 2001 and 2007.
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 Childbearing women are a well-identified group who 
represent the young, sexually active population. The 
prevalence of HIV among pregnant women attending 
ANCs included in the national sentinel surveillance 
 program has significantly declined in the last years  [6] . 
In Ugandan urban areas, between 90 and 92% of 
 pregnant women attend an ANC at some time during 
their pregnancy. However, a routine surveillance system 
such as that in Uganda often shows weaknesses such as 
missing data, inconsistencies in the samples and a lack 
of precision in estimates of HIV seroprevalence. The 
findings cannot be generalized throughout the country 
 [7, 8] .
 Our objective, therefore, was to continue a sentinel 
surveillance which was started by our group in the mid-
1990s, to determine seroprevalence trends among preg-
nant women in rural Western Uganda over a sufficient 
period of time, i.e. about 15 years. In this study, at two 
time-points, 6 years apart, i.e. in 2001 and 2007, the prev-
alence of HIV among pregnant women attending an 
ANC was determined and the results were compared. 
The data were collected as a continuation of a study that 
had already taken place more than 7 years before; in the 
1990s, we had undertaken the first study in the same 
Ugandan region  [9] that showed an overall HIV serop-
revalence among pregnant women of 21.5% (88 out of 
Table 4.  Simultaneous HIV-1 and syphilis seroprevalence in 2001 
and 2007
Year Frequency Percentage
2001 HIV+ and syphilis+ 45 9.7
HIV+ and syphilis– 87 18.7
HIV– and syphilis+ 84 18.0
HIV– and syphilis– 250 53.6
Total 466 100.0
2007 HIV+ and syphilis+ 19 3.9
HIV+ and syphilis– 101 20.8
HIV– and syphilis+ 33 6.8
HIV– and syphilis– 322 66.3
Invalid 11 2.3
Total 486 100.0
 Reduction of HIV-1 and syphilis double infections from 
2001  to 2007 (highly significant p < 0.0001). Positive: + and 
negative: –.
Table 3. Syphilis serology status by age group
Year 2001  2007
n % n %
Total n 466 486
Age, years
<15 positive 1 16.7 positive 0 0.0
negative 5 83.3 negative 1 100.0
<15–19 positive 22 24.7 positive 3 2.9
negative 67 75.3 negative 98 95.1
invalid 2 1.9
<20–24 positive 36 32.7 positive 15 9.7
negative 74 67.3 negative 137 88.4
invalid 3 1.9
<25–29 positive 33 28.9 positive 9 8.3
negative 81 71.1 negative 97 89.0
invalid 3 2.8
<30–34 positive 17 25.0 positive 10 17.5
negative 51 75 negative 46 80.7
invalid 1 1.8
<35–39 positive 14 25.5 positive 9 29.0
negative 41 74.5 negative 21 67.7
invalid 1 3.2
<40–44 positive 7 33.3 positive 1 20.0
negative 14 66.7 negative 4 80.0
>44 positive 0 0.0 positive 2 66.7
negative 2 100.0 negative 1 33.3
<Unknown positive 0 0.0 positive 5 22.7
negative 1 100.0 negative 97 72.7
invalid 3 4.5
Median 26, IQR: 20–31 24, IQR: 20–28
Summarized positive 130 27.9 positive 54 11.1
negative 336 72.1 negative 419 86.2
invalid 13 2.7
 Number and age distribution of syphilis-positive and 
 syphilis-negative pregnant women in the 2 studies in 2001 and 
2007.
 Fig. 1. Data of table 4 displayed in a column diagram. 
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409). Altogether, we could now sample the HIV serology 
of 1,361 pregnant women participating in 3 serosurveys 
in total.
 In 1993, 11.5% of pregnant women were infected with 
both HIV and syphilis. The overall syphilis seroreactiv-
ity was 39.1% (160 out of 409 women) and was linked sig-
nificantly to HIV infection (p < 0.0005)  [9] . This empha-
sizes the fact that the presence of genital ulcers or similar 
lesions increases the susceptibility of HIV infection as re-
ported in many previous studies  [10, 11] . The pathology 
which takes place is the attraction and active infiltration 
of lymphocytes and macrophages in these lesions and ul-
cers which facilitate and even force the entrance of the 
HIV into the blood circulation  [12] . Patients with any 
STD in the past 5 years – as reported in another study  [13] 
– had a significantly higher probability to be infected 
with HIV than those without such a disease history (26%; 
OR 2.08).
 Our main finding was that the HIV-1 seroprevalence 
rate among pregnant women attending an ANC in rural 
Uganda in 2001 amounted to 28.3%. This percentage rep-
resents a considerable increase (6.8%) in 8 years when 
compared to the rate of 21.5% in 1993 among pregnant 
women in the same area  [9] .
 In 2001, HIV positivity peaked among pregnant 
women in the age group 25–29 years, and in 2007 in the 
younger age group of 20–24 years. There was shift of peak 
HIV prevalence to younger pregnant women. The 
comparison does reflect, however, the whole pregnant 
population participating in the two anonymous sentinel 
surveillances of the years 2001 and 2007. Therefore, our 
studies in Uganda in sub-Saharan East Africa may not 
necessarily reveal a real shift of HIV infection to an 
earlier onset in pregnant women.
 This high prevalence of HIV-1 infection, particularly 
among young fertile women, is similar to the results of 
other East African population-based studies  [14] . The in-
creasing incidence of HIV in rural areas is often concen-
trated in younger age groups. The increased morbidity 
and mortality rates and the fertility problems associated 
with HIV in the late 1990s may reflect the still-existing 
lack of behavioral change or improvement in STD case 
management  [15] . These findings indicate that, in spite 
of the high level of HIV awareness in Uganda, the sero-
prevalence rate still rose in rural areas in the late 1990s, 
which correlates with data from other studies  [16] . An 
inversion of this situation may be expected in the next 
few years, as this trend was seen in these latest data of 
2007 when we found a reduction of HIV seropositivity to 
25.1%. Our study showed an overall reduction of HIV 
prevalence of 3.2% in rural Uganda from 2001 to 2007. 
Over the past 20 years, several other studies have also 
shown a considerable decline of HIV prevalence among 
pregnant women attending ANCs in urban areas. For 
years, urban data have shown a decrease of HIV serop-
revalence in the population  [8] . This trend is less pro-
nounced in the countryside. Even if our decrease in HIV 
seroprevalence seems to be minor in comparison to oth-
er studies reporting higher reduction rates of HIV infec-
tion  [16] , we did uncover an enormous decrease in syph-
ilis seroprevalence: from 27.9 to 11.1%. Thus, this de-
crease indicates a tremendous behavioral change in the 
population, and a continuation of this change may pro-
spectively further reduce seroprevalence rates of STDs in 
Uganda. It has even been postulated that the level of 
syphilis prevalence in a population may function as a 
prognostic factor for the development of HIV seropreva-
lence  [17] .
 During the last decades, many efforts have been 
 started in Uganda to fight the further spread of 
HIV  infection, such as educational programs about viral 
transmission  [18, 19] . In addition, a network of 
 counseling for people living with HIV has been estab-
lished  [20] .
 As also mentioned in other studies, one limitation 
 exists with regard to data taken from ANCS on HIV 
prevalence: as infertile women or women using modern 
contraception do not visit ANCs, these women are 
 obviously not represented in the studies concerning 
HIV in pregnancy. The exclusion of this group of wom-
en may result in an underestimation of HIV prevalence 
in the female population because infertility is mostly 
caused by STDs including HIV  [21–26] . Other studies 
have shown that fertility rates decrease with HIV infec-
tion  [15] . The reduced incidence of recognized pregnan-
cy and fertility in the earliest stages of HIV infection is 
consistent with a previous observation, i.e. an associa-
tion between pre-existing sub-fertility and subsequent 
HIV infection in this cohort  [27] . No data are available 
as to whether the women recruited for our studies had 
wanted to become pregnant. Many clinicians are un-
aware of the serostatus of the pregnant women attending 
an ANC without symptoms, and the extent of women’s 
suspicions of their HIV status is unknown. Although 
other studies suggest that pregnancy does not involve 
further physiological risks of acquiring HIV-1, unpro-
tected sex (unless in a known monogamous relation-
ship) clearly represents a behavioral risk for HIV-1 ac-
quisition  [28] .
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 Conclusion 
 In summary, the HIV prevalence rate in Uganda de-
creased after 1993 but remained stable at a high level be-
tween 2001 and 2007. The infection rate of syphilis, how-
ever, decreased significantly. This might be a strong pre-
dictor of decreasing prevalence rates in HIV in the 
coming years. There is still a lot to do regarding the pre-
vention of HIV infection and there is a great need for 
health care professionals and counselors to provide ser-
vices for women and men infected with HIV.
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